MedTrace Logo

The Research of the Effect of Sevoflurane on Brain-protection of Cardiac Surgery in Infants.

NCT03366597 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-02-11

No results posted yet for this study

Summary

To observe the effect of sevoflurane on the concentration of S100β and regional cerebral oxygen saturation in infants with congenital heart disease undergoing cardiac surgery.

Conditions

  • Congenital Heart Disease
  • Infant, Premature, Diseases

Interventions

DRUG

Sevoflurane

1.5%-3% Sevoflurane will be given during the cardiac surgery except cardiopulmonary bypass.

Sponsors & Collaborators

  • Jun Ma

    lead OTHER

Principal Investigators

  • Boqun Cui, M.D. · Beijing Anzhen Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-20
Primary Completion
2021-12-28
Completion
2022-12-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366597 on ClinicalTrials.gov